Navigation Links
DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks
Date:5/24/2013

Toronto, Canada (PRWEB) May 24, 2013

Many factors impact tissues targeting such as protein binding, selective barriers, and uptake or efflux transporters at the blood-tissue barrier. Even when tissue disposition is achieved, activity may be related to unbound fractions in the tissue rather than the total tissue concentration.

A thorough understanding of these disposition challenges is required to guide lead optimization, predict in vivo activity in animal models, and to identify any species-dependent variables that may impact the likely human clinical dose.

In this webinar we will discuss:

  •     A tissue disposition-driven rationale to support lead optimization.
  •     The bioanalytical strategy employed for high efficiency tissue analysis.
  •     For an anti-infective, use of in vitro time-kill and reversibility kinetics to correlate exposure (based on unbound concentrations in tissue) to pharmacodynamic measures that best predict efficacy.
  •     Compound modification and pro-drugging strategies for targeted tissue disposition, and rejuvenation of intellectual property

For more information about this event, visit: http://xtalks.com/DMPK-for-Targeted-Tissue-Delivery.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10765751.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Thomson Reuters Research Forecasts the Onset of the Targeted Drug Discovery Era
2. Harvards Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses
3. Targeted antibacterial agent rapidly created in response to serious food safety pathogen
4. First targeted and programmable nanomedicine to show clinical antitumor effects published
5. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
6. Parthenon Identifies Emerging Opportunities in Targeted Payload Cancer Therapeutics
7. First-of-its-kind self-assembled nanoparticle for targeted and triggered thermo-chemotherapy
8. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
9. Study identifies targeted molecular therapy for untreatable NF1 tumors
10. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
11. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):